Experts have noted an increase in eating disorders among patients taking popular weight loss drugs like Wegovy or Zepbound. These drugs mimic a naturally occurring hormone that curbs hunger and regulates blood sugar levels, leading to significant weight loss in some cases. However, some individuals, particularly those with a history of unhealthy relationships with food, may develop or worsen eating disorders while taking these medications. Concerns have been raised about the abuse of these drugs for weight loss, with reports of increased risk of misuse among patients taking semaglutide, the active ingredient in some of these medications.
Some patients have reported developing restrictive eating habits and obsessive thoughts about food while taking these drugs, leading to the escalation of an eating disorder. Patients who have a history of binge eating may also be at risk of worsening symptoms while taking GLP-1 drugs. Doctors have been urged to screen patients for eating disorders before prescribing these medications and to closely monitor their weight and behaviors.
While some experts have reported positive outcomes for patients with binge eating disorder, others worry that these drugs could exacerbate eating disorder symptoms in some individuals. Safety concerns have been raised for children and adolescents who may be prescribed these medications without proper screening. It is recommended that patients who are considering or currently taking these weight loss drugs also seek mental health support to monitor any potential changes in eating behaviors.
Photo credit
www.nbcnews.com